Of the 98 patients with IgM monoclonal gammopathies, the mutational status of MYD88 could be evaluated in 84 patients (84/98 patients, 86%) by tDNA and in 84 patients (84/98 patients, 86%) by cfDNA. Here, MYD88 is linked to monoclonal gammopathy.